Talat Imran | executive |
Arvinder Dhalla | executive |
Svai Sanford | executive |
Olivia Brayer | analyst |
Edward Nash | analyst |
Julian Harrison | analyst |
John Vandermosten | analyst |
Welcome to the Rani Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. [Operator Instructions].
As a reminder, this call is being recorded today, Wednesday, March 20, 2024.
I would now like to turn the conference call over to Kiki Patel at Gilmartin Group. Please go ahead.